已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis

甲状腺癌 肿瘤科 医学 内科学 癌症 甲状腺癌 原发性癌症 甲状腺 数据库 计算机科学
作者
Jianhua Feng,Caixiu Wu,Fei Shen,Wen-song Cai,Bo Xu
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [Oxford University Press]
被引量:1
标识
DOI:10.1210/clinem/dgae501
摘要

Abstract Context Adult cancer survivors are at a heightened risk for secondary primary differentiated thyroid carcinoma (2-DTC). The characteristics and outcomes of 2-DTC remain poorly understood. Objective We aimed to explore the characteristics and outcomes of 2-DTC. Methods We retrospectively analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2017). 2-DTC was divided into 25 subgroups based on prior primary malignancies (PPMs). Baseline characteristics were compared using the chi-square test. Multivariable logistic analysis was used to identified if PPMs were associated with aggressive DTC characteristics. DTC-specific and cancer-specific mortality were analyzed using a univariable and multivariable competing risk regression model. Results There were 138 555 1-DTC and 9253 2-DTC patients identified. 2-DTC patients were predominantly older, male, and White compared to first primary DTC (1-DTC) (all P < .05). In multivariable logistic regression analysis, only 4 types of PPMs were associated with higher rates of DTC aggressive characteristics, while 19 types exhibited lower rates (all P < .05). In multivariable competing risk analysis, 2-DTC showed no mortality risk in stages I (SHR: 1.16; 95% CI, 0.65-2.07) and II (SHR: 0.67; 95% CI, 0.45-1.01), but a protective role in stages III (SHR: 0.47; 95% CI, 0.27-0.83) and IV (SHR: 0.72; 95% CI, 0.52-0.99). Most PPMs that developed into 2-DTC had a lower risk of DTC-specific death than 1-DTC, but many PPMs had a higher risk of cancer-specific death. Conclusion Given the characteristics and outcomes of 2-DTC, aggressive treatment for 2-DTC, particularly for PPM with a high mortality risk, may not be advisable.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Joehq_1203应助南音采纳,获得10
2秒前
风中小懒虫完成签到,获得积分10
2秒前
小天小天完成签到 ,获得积分10
2秒前
111完成签到 ,获得积分10
2秒前
拼搏的败完成签到 ,获得积分10
5秒前
5秒前
科研通AI2S应助Tiscen采纳,获得10
5秒前
Tanyang完成签到 ,获得积分10
5秒前
5秒前
6秒前
7秒前
7秒前
白昼完成签到 ,获得积分10
8秒前
15发布了新的文献求助10
10秒前
10秒前
10秒前
11秒前
潇洒的代双完成签到,获得积分10
11秒前
aha发布了新的文献求助10
11秒前
JamesPei应助yww采纳,获得10
12秒前
memebao完成签到,获得积分10
13秒前
15秒前
居蓝完成签到 ,获得积分10
15秒前
15秒前
15秒前
费老五完成签到 ,获得积分10
16秒前
sunny发布了新的文献求助10
17秒前
17秒前
科研通AI2S应助古琴残梦采纳,获得10
17秒前
20秒前
21秒前
盛夏夜未眠完成签到,获得积分10
22秒前
毛123完成签到,获得积分10
22秒前
天天快乐应助KSung采纳,获得10
24秒前
隐形曼青应助KSung采纳,获得10
24秒前
搜集达人应助KSung采纳,获得10
24秒前
怡然的凌兰应助KSung采纳,获得10
24秒前
可爱的函函应助KSung采纳,获得10
24秒前
英姑应助KSung采纳,获得10
24秒前
科研通AI6.2应助KSung采纳,获得10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6165056
求助须知:如何正确求助?哪些是违规求助? 7992562
关于积分的说明 16619679
捐赠科研通 5271867
什么是DOI,文献DOI怎么找? 2812621
邀请新用户注册赠送积分活动 1792715
关于科研通互助平台的介绍 1658583